Israel and South Korea agree to COVID-19 vaccine exchange - report | Inquirer News

Israel and South Korea agree to COVID-19 vaccine exchange – report

/ 10:42 AM July 06, 2021
pfizer israel

A vial of the Pfizer vaccine against the coronavirus disease (COVID-19) is seen as medical staff are vaccinated at Sheba Medical Center in Ramat Gan, Israel December 19, 2020. REUTERS FILE PHOTO

SEOUL — Israel agreed on Monday to provide about 700,000 expiring doses of Pfizer-BioNTech’s coronavirus vaccine to South Korea, the Haaretz newspaper reported, citing Israeli Prime Minister Naftali Bennett.

Delivery of the doses is to begin later in July, and as part of the deal Israel will receive in September and October an identical number of Pfizer vaccine doses that had been ordered by Seoul, Bennett said.

ADVERTISEMENT

A spokeswoman for South Korea’s Health Ministry said on Tuesday she had no comment on the report.

South Korea has quickly distributed the COVID-19 vaccines it has, but has struggled to obtain enough doses in a timely manner amid tight global supplies, particularly in Asia.

FEATURED STORIES

The government said last week it is hoping to achieve herd immunity earlier than its November target by inoculating at least 70% of its population with a minimum of one vaccine dose, mostly mRNA ones such as Pfizer’s.

Read Next
Don't miss out on the latest news and information.

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: COVID-19 Vaccines, international relations, Israel, Pfizer, South korea
For feedback, complaints, or inquiries, contact us.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.



© Copyright 1997-2022 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.